By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 51
NEW YORK (Reuters Health) – When a child has a Staphylococcus aureus skin abscess, decolonizing all household members rather than just the individual patient leads to a lower…
NEW YORK (Reuters Health) – Three years of weekly treatment with a sustained-release formulation of growth hormone is as safe and effective as standard daily growth hormone (GH)…
NEW YORK (Reuters Health) – Patients requiring chronic nonsteroidal anti-inflammatory drug (NSAID) treatment develop fewer gastric or duodenal ulcers if they take ibuprofen with high-dose famotidine in a…
NEW YORK (Reuters Health) – Long-term outcomes are better for patients with three-vessel coronary artery disease when they undergo off-pump coronary artery bypass grafting rather than percutaneous coronary…
NEW YORK (Reuters Health) – For the nonsurgical management of first-trimester miscarriage, delayed medical treatment (i.e., monitoring for expulsion followed, if needed, by mifepristone and/or misoprostol) “may not…
NEW YORK (Reuters Health) – In methamphetamine-dependent adults, treatment with the anticonvulsant topiramate (Topamax; Ortho-McNeil Neurologics) does little to promote abstinence, but it seems to help those on…
NEW YORK (Reuters Health) – Intravaginal progesterone is a valid alternative to intramuscular administration for luteal phase support in women undergoing in vitro fertilization, according to the results…
NEW YORK (Reuters Health) – While the CYP2C19 genotype is associated with platelet response to clopidogrel, that does not equate with any meaningful effect on clinical outcomes, according…
NEW YORK (Reuters Health) – In patients presenting with chest pain, troponin I levels measured on admission and at 3 hours reliably rule out or rule in acute…
NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab…
